LPCAT1 , the Enzyme Responsible for Converting LPC to PC , Promotes OPC Differentiation In Vitro
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Qi Shang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Key Laboratory of Molecular Neurobiology of the Ministry of Education, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: 1-Acylglycerophosphocholine O-Acyltransferase, Cell Differentiation, Lysophosphatidylcholines, Oligodendroglia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Myelin is the key structure for high‐speed information transmission and is formed by oligodendrocytes (OLs) which are differentiated from oligodendrocyte precursor cells (OPCs) in the central nervous system. Lipid is the main component of myelin and the role of lipid metabolism‐related molecules in myelination attach increasing attention. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) mediates the conversion of lysophosphatidylcholine (LPC) to phosphatidylcholine (PC), and its role in myelination draws our interest as LPC is a classical demyelination inducer and PC is a major component of myelin. In this work, LPCAT1 is found expressed in the oligodendrocyte lineage cells during myelination. In vitro experiments showed that the expression level of LPCAT1 gradually increased along with the differentiation process from OPCs to OLs, and over‐expression and interference experiments showed that LPCAT1 promoted OPCs differentiation without affecting their proliferation or apoptosis. Mechanistically, the undertaker of LPCAT1's pro‐differentiation role is not PC, but the phosphorylated mTOR which is a key regulator in OPCs differentiation. RNA sequencing analysis showed LPCAT1 promoted the expression of ZBTB20 which is an important transcription factor related to lipid metabolism and regulates mTOR phosphorylation. In vivo, complex myelin tomacula involving multiple axons was formed after conditionally knocking out LPCAT1 in oligodendrocyte lineage cells, but no obvious myelin thickness abnormalities were observed. Our results indicate that LPCAT1 is an important regulator of myelination, and lipid metabolism‐related molecules may be new valuable targets for the treatment of diseases with myelin abnormalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, Key Laboratory of Molecular Neurobiology of the Ministry of Education, Naval Medical University, Shanghai, China.
- Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, China.
- Department of Anesthesiology, Changzheng Hospital, Naval Medical University, Shanghai, China.
- Department of Neurology, Naval Specialty Medical Center, Naval Medical University, Shanghai, China.
ORCID-Profile: Dingya Sun
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shang, Q., Zhang, X., Pu, Y., Lin, J., Ma, P., Pan, Y., Zhao, M., Sun, D., & Cao, L. (2025). LPCAT1 , the Enzyme Responsible for Converting LPC to PC , Promotes OPC Differentiation In Vitro. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70387
Vancouver
Shang Q, Zhang X, Pu Y, Lin J, Ma P, Pan Y, et al. LPCAT1 , the Enzyme Responsible for Converting LPC to PC , Promotes OPC Differentiation In Vitro. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70387
BibTeX
@article{Shang2025,
author = {Shang, Qi and Zhang, Xin and Pu, Yingyan and Lin, Junjian and Ma, Peng and Pan, Yuchen and Zhao, Ming and Sun, Dingya and Cao, Li},
title = {LPCAT1 , the Enzyme Responsible for Converting LPC to PC , Promotes OPC Differentiation In Vitro},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70387}
}
EUVIMED